These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11583486)

  • 1. Histopathology of chronic renal allograft dysfunction.
    Furness PN
    Transplantation; 2001 Jun; 71(11 Suppl):SS31-6. PubMed ID: 11583486
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver allograft rejection: current status of classification and grading.
    Batts K
    Transplant Proc; 1996 Feb; 28(1):453-6. PubMed ID: 8644312
    [No Abstract]   [Full Text] [Related]  

  • 3. SDF-1 expression is elevated in chronic human renal allograft rejection.
    Hoffmann U; Banas B; Krüger B; Banas M; Bergler T; Böger C; Kammerl M; Obed A; Rümmele P; Segerer S; Riegger GA; Krämer BK
    Clin Transplant; 2006; 20(6):712-8. PubMed ID: 17100720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of subclinical rejection in early renal allograft biopsies for chronic allograft dysfunction.
    Miyagi M; Ishikawa Y; Mizuiri S; Aikawa A; Ohara T; Hasegawa A
    Clin Transplant; 2005 Aug; 19(4):456-65. PubMed ID: 16008588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of renal allograft histopathology: a comparative study of single-lesion histology versus a composite, quantitative scoring system.
    Yilmaz S; McLaughlin K; Paavonen T; Taskinen E; Monroy M; Aavik E; Vamvakopoulos J; Häyry P
    Transplantation; 2007 Mar; 83(6):671-6. PubMed ID: 17414693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of the Banff classification in subclinical kidney transplant rejection.
    Veronese FV; Manfro RC; Roman FR; Edelweiss MI; Rush DN; Dancea S; Goldberg J; Gonçalves LF
    Clin Transplant; 2005 Aug; 19(4):518-21. PubMed ID: 16008598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic grading of pancreas acute allograft rejection in percutaneous needle biopsies.
    Drachenberg C; Klassen D; Bartlett S; Hoehn-Saric E; Schweitzer E; Johnson L; Weir M; Papadimitriou J
    Transplant Proc; 1996 Feb; 28(1):512-3. PubMed ID: 8644332
    [No Abstract]   [Full Text] [Related]  

  • 8. Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcome.
    Masin-Spasovska J; Spasovski G; Dzikova S; Grcevska L; Petrusevska G; Lekovski Lj; Popov Z; Ivanovski N
    Transplant Proc; 2005 Mar; 37(2):705-8. PubMed ID: 15848508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of cytotoxic T-lymphocytes and CD40 in biopsies with early renal allograft rejection.
    Mengel M; Mueller I; Behrend M; von Wasielewski R; Radermacher J; Schwarz A; Haller H; Kreipe H
    Transpl Int; 2004 Jul; 17(6):293-300. PubMed ID: 15221125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor expression in patients with renal allograft dysfunction.
    Kwon J; Park J; Lee D; Kim YS; Jeong HJ
    Transplant Proc; 2008 Dec; 40(10):3479-80. PubMed ID: 19100417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal pathology in the pediatric transplant patient.
    Vogler C; Wang Y; Brink DS; Wood E; Belsha C; Walker PD
    Adv Anat Pathol; 2007 May; 14(3):202-16. PubMed ID: 17452817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To biopsy or not to biopsy? Should we screen the histology of stable renal grafts?
    Thaunat O; Legendre C; Morelon E; Kreis H; Mamzer-Bruneel MF
    Transplantation; 2007 Sep; 84(6):671-6. PubMed ID: 17893596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening biopsies in kidney transplantation: from subclinical acute rejection to chronic allograft lesions].
    Snanoudj R; Martinez F; Sberro Soussan R; Thervet E; Legendre C
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S192-9. PubMed ID: 19000886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allograft dysfunction post renal transplant.
    Weiskittel P
    Nephrol Nurs J; 2003 Feb; 30(1):79-80. PubMed ID: 12674956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of chronic renal allograft dysfunction].
    Morozumi K; Takeda A; Uchida K
    Hinyokika Kiyo; 2002 Nov; 48(11):673-7. PubMed ID: 12512140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients.
    Helantera I; Koskinen P; Tornroth T; Loginov R; Gronhagen-Riska C; Lautenschlager I
    Transplantation; 2003 Jun; 75(11):1858-64. PubMed ID: 12811246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic allograft nephropathy: what have we learned from protocol biopsies?
    Bosmans JL; Ysebaert DK; Verpooten GA
    Transplantation; 2008 Apr; 85(7 Suppl):S38-41. PubMed ID: 18401262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol biopsies after kidney transplantation.
    Böhmig GA; Regele H; Hörl WH
    Transpl Int; 2005 Feb; 18(2):131-9. PubMed ID: 15691264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
    Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of B lymphocytes (CD20+) in renal allograft biopsy specimens.
    Martins HL; Silva C; Martini D; Noronha IL
    Transplant Proc; 2007 Mar; 39(2):432-4. PubMed ID: 17362749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.